Kaleorid Lp

Potassium Chloride, the active ingredient in Kaleorid Lp, is a potassium supplement presented as an oral formulation for oral use. It is employed to correct low serum potassium levels (hypokalemia) in patients requiring electrolyte restoration. The product is indicated when potassium loss occurs due to diuretic therapy, gastrointestinal losses, or metabolic disorders, helping to maintain normal cardiac and muscular function.

GNH USA supplies Kaleorid Lp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaleorid Lp is used to address conditions associated with potassium deficiency and related electrolyte disturbances.

- Hypokalemia: restores normal serum potassium concentrations and reduces symptoms of potassium deficiency. - Diuretic‑induced potassium loss: prevents depletion of potassium during treatment with loop or thiazide diuretics. - Cardiac arrhythmia risk due to low potassium: helps maintain cardiac electrical stability by correcting potassium levels.

Oral potassium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: cramping or pain in the stomach area. - Constipation or diarrhea: changes in bowel movements. - Metallic taste: transient taste alteration.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high potassium levels that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeat potentially leading to serious complications. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Muscle weakness or paralysis: rare neuromuscular effects.

When prescribing Kaleorid Lp, clinicians should consider several safety measures to minimize risks.

- Monitor serum potassium: regular blood tests to ensure levels remain within target range. - Adjust dose in renal impairment: reduce dosage or increase monitoring in patients with reduced kidney function. - Avoid use in hyperkalemia: contraindicated when serum potassium is already elevated. - Caution with ACE inhibitors or ARBs: these agents can increase potassium and require closer observation. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk; consult prescriber. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium chloride can interact with several medications, altering potassium balance or drug effectiveness.

Major Interactions (Avoid): - ACE inhibitors, ARBs, potassium‑sparing diuretics: combined use may cause life‑threatening hyperkalemia. - NSAIDs: can reduce renal potassium excretion and raise serum levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers and digoxin: elevated potassium may enhance drug effects; monitor cardiac function. - Insulin or glucose therapy: shifts potassium into cells, requiring potassium level checks. - Trimethoprim‑sulfamethoxazole: may increase serum potassium; monitor regularly. - Heparin: can cause mild hyperkalemia; observe potassium concentrations.